Article Details

Key third-quarter readouts for big pharma

Retrieved on: 2021-06-28 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Key third-quarter readouts for big pharma. View article details on hiswai:

Excerpt

Over the next three months Astrazeneca/Alexion's Ultomiris will get a turn in myasthenia gravis, while data are also expected on Pfizer/Roche's gene ...

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo